MedTrace Logo

Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease

NCT01168154 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2011-06-28

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness and the tolerability of the Lactobacillus reuteri in the control of the diverticular disease symptoms and in the prevention of acute diverticulitis episodes.

Conditions

  • Diverticulosis
  • Diverticulitis

Interventions

DIETARY_SUPPLEMENT

Lactobacillus Reuterii

Lactobacillus Reuterii 10000000000 CFU per day

DIETARY_SUPPLEMENT

placebo

placebo

Sponsors & Collaborators

  • Careggi Hospital

    collaborator OTHER

  • Casa Sollievo della Sofferenza IRCCS

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168154 on ClinicalTrials.gov